Total Payments
$10,444
2024 Payments
$487.76
Companies
28
Transactions
382
Medicare Patients
4,257
Medicare Billing
$289,138
Payment Breakdown by Category
Food & Beverage$10,174 (97.4%)
Education$269.71 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,174 | 376 | 97.4% |
| Education | $269.71 | 6 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,439 | 102 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,193 | 58 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $1,024 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $740.57 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $700.04 | 23 | $0 (2023) |
| Amgen Inc. | $475.72 | 16 | $0 (2023) |
| Lilly USA, LLC | $399.30 | 10 | $0 (2024) |
| Galderma Laboratories, L.P. | $384.92 | 7 | $0 (2024) |
| UCB, Inc. | $380.43 | 20 | $0 (2024) |
| LEO Pharma Inc. | $373.16 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $487.76 | 19 | ABBVIE INC. ($165.52) |
| 2023 | $2,504 | 93 | AbbVie Inc. ($540.09) |
| 2022 | $3,320 | 123 | ABBVIE INC. ($969.31) |
| 2021 | $3,447 | 114 | AbbVie Inc. ($591.21) |
| 2020 | $684.92 | 33 | AbbVie Inc. ($173.17) |
All Payment Transactions
382 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: DERMATOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.57 | General |
| 11/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $30.03 | General |
| Category: Immunology | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $84.00 | General |
| 09/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $52.34 | General |
| Category: Dermatology | ||||||
| 10/19/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: Immunology | ||||||
| 08/21/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Immunology | ||||||
| 07/27/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 07/24/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.63 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 650 | 1,183 | $206,418 | $36,879 |
| 2022 | 13 | 1,166 | 2,228 | $434,998 | $83,930 |
| 2021 | 16 | 1,623 | 2,945 | $567,731 | $116,768 |
| 2020 | 12 | 818 | 1,462 | $243,067 | $51,561 |
Total Patients
4,257
Total Services
7,818
Medicare Billing
$289,138
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 310 | $83,079 | $15,173 | 18.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 100 | 120 | $41,552 | $7,726 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 104 | 131 | $26,438 | $4,366 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 63 | $24,069 | $3,933 | 16.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $12,788 | $2,159 | 16.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 71 | 423 | $8,749 | $1,837 | 21.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 22 | 22 | $6,724 | $1,100 | 16.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $2,671 | $536.64 | 20.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 60 | $348.96 | $48.25 | 13.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 402 | 614 | $170,692 | $33,778 | 19.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 170 | 217 | $78,817 | $15,823 | 20.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 166 | 230 | $48,666 | $8,448 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 97 | $38,218 | $7,746 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 67 | 67 | $23,179 | $3,943 | 17.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 56 | 58 | $18,888 | $3,552 | 18.8% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 21 | 70 | $15,811 | $2,938 | 18.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 106 | 669 | $14,711 | $2,894 | 19.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 23 | $11,767 | $2,625 | 22.3% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 21 | 32 | $5,707 | $965.76 | 16.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2022 | 16 | 18 | $5,196 | $621.83 | 12.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 14 | $2,394 | $500.50 | 20.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 42 | 119 | $952.00 | $95.31 | 10.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 397 | 581 | $154,121 | $33,698 | 21.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 235 | 296 | $107,510 | $22,581 | 21.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 168 | $62,090 | $14,843 | 23.9% |
About Dr. Parul Shah, MD
Dr. Parul Shah, MD is a Dermatology healthcare provider based in Boynton Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851462774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Parul Shah, MD has received a total of $10,444 in payments from pharmaceutical and medical device companies, with $487.76 received in 2024. These payments were reported across 382 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($10,174).
As a Medicare-enrolled provider, Shah has provided services to 4,257 Medicare beneficiaries, totaling 7,818 services with total Medicare billing of $289,138. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Boynton Beach, FL
- Active Since 11/13/2006
- Last Updated 08/20/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1851462774
Products in Payments
- SKYRIZI (Biological) $1,477
- COSENTYX (Biological) $853.79
- TREMFYA (Drug) $825.04
- LIBTAYO (Biological) $725.17
- DUPIXENT (Biological) $575.08
- HUMIRA (Biological) $507.09
- RINVOQ (Biological) $435.73
- Otezla (Drug) $421.98
- Cimzia (Drug) $351.19
- Sotyktu (Drug) $328.50
- TALTZ (Drug) $294.50
- Ilumya (Biological) $282.00
- ADBRY (Biological) $274.58
- OPZELURA (Drug) $259.63
- COSENTYX (Drug) $259.46
- Winlevi (Drug) $249.47
- EUCRISA (Drug) $201.25
- AKLIEF (Drug) $187.10
- ZILXI (Drug) $124.08
- ARAZLO (Drug) $121.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Boynton Beach
Dr. Robyn Siperstein, M.d, M.D
Dermatology — Payments: $687,046
Dermatology $687,046
Dr. Joshua Berlin, Md, MD
Dermatology — Payments: $392,406
Dermatology $392,406
Dr. Julian Mackay-Wiggan, M.d, M.D
Dermatology — Payments: $173,470
Dermatology $173,470
Dr. William Roth, M.d, M.D
Dermatology — Payments: $22,356
Dermatology $22,356
Dr. Andrei Gherghina, Do, Ms, DO, MS
Dermatology — Payments: $11,820
Dermatology $11,820
Dr. Amelia Damse, D.o., M.p.h, D.O., M.P.H
Dermatology — Payments: $6,217
Dermatology $6,217